Literature DB >> 10510391

TNF is essential for the cell-mediated protective immunity induced by the radiation-attenuated schistosome vaccine.

M Street1, P S Coulson, C Sadler, L J Warnock, D McLaughlin, H Bluethmann, R A Wilson.   

Abstract

C57BL/6 mice exposed to the radiation-attenuated schistosome vaccine exhibit high levels of protective immunity. The cell-mediated pulmonary effector mechanism involves IFN-gamma-producing CD4+ T cells in a focal response around challenge larvae. IFN-gamma can promote production of TNF and can synergize with this cytokine in its actions on responder cells. We have examined whether TNF plays a role in lung phase immunity to schistosomes using mice with a disrupted gene for TNFRI (TNFRI-/-). The most dramatic finding was that the schistosome vaccine elicited no protection whatsoever in these mice. However, this could not be attributed to a lack of responder cells, because more lymphocytes were lavaged from the airways of TNFRI-/- than wild-type mice. Furthermore, CD4+ T cells were equally represented in airway populations from the two groups and produced IFN-gamma upon Ag stimulation in vitro. In contrast, pulmonary macrophage function was defective in TNFRI-/- mice, as indicated by a failure to up-regulate inducible NO synthase mRNA. Histopathological analysis revealed that focal infiltrates were of similar size and cell composition in the two groups but that more parasites were free of foci in the TNFRI-/- mice. These animals had a greatly impaired IgG response to schistosomes, which may explain their lack of residual protection due to Ab in a situation where cell-mediated immunity is disabled. We suggest that the absence of protective immunity could result from a retarded build-up of leukocytes around migrating lung worms and/or a deficit in accessory cell function within a focus, both of which would permit parasite escape.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510391

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Schistosoma mansoni triggers Dectin-2, which activates the Nlrp3 inflammasome and alters adaptive immune responses.

Authors:  Manuel Ritter; Olaf Gross; Sarah Kays; Jürgen Ruland; Falk Nimmerjahn; Shinobu Saijo; Jürg Tschopp; Laura E Layland; Clarissa Prazeres da Costa
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

2.  Signaling via interleukin-4 receptor alpha chain is required for successful vaccination against schistosomiasis in BALB/c mice.

Authors:  A P Mountford; K G Hogg; P S Coulson; F Brombacher
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  CD40/CD154 interactions are required for the optimal maturation of skin-derived APCs and the induction of helminth-specific IFN-gamma but not IL-4.

Authors:  James P Hewitson; Gavin R Jenkins; Paul A Hamblin; Adrian P Mountford
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

4.  Tumor necrosis factor (TNF) protects resistant C57BL/6 mice against herpes simplex virus-induced encephalitis independently of signaling via TNF receptor 1 or 2.

Authors:  Patric Lundberg; Paula V Welander; Carl K Edwards; Nico van Rooijen; Edouard Cantin
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

Review 5.  Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour.

Authors:  R Alan Wilson; Patricia S Coulson
Journal:  Trends Parasitol       Date:  2009-08-28

6.  In the absence of CD154, administration of interleukin-12 restores Th1 responses but not protective immunity to Schistosoma mansoni.

Authors:  James P Hewitson; Paul A Hamblin; Adrian P Mountford
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

7.  Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages.

Authors:  Sheila Donnelly; Colin M Stack; Sandra M O'Neill; Ahmed A Sayed; David L Williams; John P Dalton
Journal:  FASEB J       Date:  2008-08-15       Impact factor: 5.191

8.  Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.

Authors:  Adebayo J Molehin; Souad R Sennoune; Weidong Zhang; Juan U Rojo; Arif J Siddiqui; Karlie A Herrera; Laura Johnson; Justin Sudduth; Jordan May; Afzal A Siddiqui
Journal:  Parasitol Res       Date:  2017-10-12       Impact factor: 2.289

Review 9.  Granulocytes in helminth infection -- who is calling the shots?

Authors:  B L Makepeace; C Martin; J D Turner; S Specht
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

10.  Schistosoma tegument proteins in vaccine and diagnosis development: an update.

Authors:  Cristina Toscano Fonseca; Gardênia Braz Figueiredo Carvalho; Clarice Carvalho Alves; Tatiane Teixeira de Melo
Journal:  J Parasitol Res       Date:  2012-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.